Elevating Imaging, Empowering Flow – AGFA HealthCare at RSNA 2025 
Radisson Continues to Expand Scope of Gold Mineralization at O’Brien with Latest Drill Results 
True Unlimited TravelKon Europe eSIM with 3UK Partnership Transforms Connectivity Across the UK and 70 Global Destinations 
From Global Collaboration to Energy Innovation: Neutrino Energy Group Publishes the Master Formula of Neutrinovoltaics 
Everest Medicines Announces 2025 Interim Results: ‘Dual-Engine’ Strategy Driving Strong Synergies Between Commercialization and R&D ASSEMBLE Protocol (ASM) is now supported on Coinbase Custody
KOWLOON TONG, HONG KONG / ACCESSWIRE / May 4, 2021 / The leading blockchain-based global…
Empirix KLERITY brings Assurance for 5G Standalone and IoT networks, now available on Microsoft Azure
KLERITY provides cloud-native network and service assurance throughout the entire lifecycle of 5G private and…
ThreatQuotient Launches Data-Driven Approach to SOAR and XDR, Accelerating Detection & Response
Leader in security operations solutions continues industry-first innovations with a new platform capability to streamline…
PBC Biomed to lead consortium in development of bone adhesive
SHANNON, Ireland, May 04, 2021 (GLOBE NEWSWIRE) — PBC Biomed, an Irish-based Medical Device Company,…
Tower One Announces Filing of Its Q4 and Year 2020 Annual Report
VANCOUVER, British Columbia, May 04, 2021 (GLOBE NEWSWIRE) — TOWER ONE WIRELESS CORP. (CSE: TO)…
Change of Company Name
HONG KONG, SHANGHAI, China and FLORHAM PARK, N.J., May 04, 2021 (GLOBE NEWSWIRE) — HUTCHMED…
CORRECTION: Vistin Pharma ASA : Key information relating to the cash dividend
This is a correction of the announcement from 30.04.2021, 11:22 CEST. Reason for the correction:…
Verona Pharma to Present Expanded Analysis of Phase 2b COPD Data with Ensifentrine at the American Thoracic Society 2021 International Conference
Posters highlight ensifentrine’s safety profile and its potential to improve lung function and quality of…
Invitation to Orion’s Virtual Capital Markets Day on 26 May 2021
ORION CORPORATION INVESTOR NEWS 4 MAY 2021 at 9.00 EEST Invitation to Orion’s Virtual Capital…
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – March 31, 2021
Message from the CEO IBT is conducting a phase III-study (“The Connection Study”) which is…
Immunicum AB (publ) Interim Report January – March 2021
Press Release 4 May 2021 Immunicum AB (publ) Interim Report January – March 2021 JANUARY…
Nicox’s Licensee Bausch + Lomb Launches VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024% in Taiwan and Receives Approval in Qatar
Press Release Nicox’s Licensee Bausch + Lomb Launches VYZULTA®(latanoprostene bunod ophthalmic solution), 0.024% in Taiwan…
ObsEva Announces Enrollment Completion of Linzagolix Phase 3 EDELWEISS 3 Trial for Patients with Moderate to Severe Endometriosis-Associated Pain
– EDELWEISS 3 trial of Yselty® expected to report topline data as planned in Q4:21-…
Innate Pharma Announces Conference Call and Webcast for 2021 First Quarter Business Update
MARSEILLE, France, May 04, 2021 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH –…
NovoBiome launched to revolutionize treatment of liver diseases by targeting the microbiome-gut-liver axis
NovoBiome launched to revolutionize treatment of liver diseases by targeting the microbiome-gut-liver axis First biotech…
Innate Pharma Announces Conference Call and Webcast for 2021 First Quarter Business Update
Marseille, France, May 04, 2021 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH –…
Acacia Pharma Announces Early Repayment of Loan Facility from Hercules Technology Growth Capital and Reduction in Debt Service Obligations
THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION Acacia Pharma Announces Early Repayment of…
Syneos Health Announces Pricing of Secondary Offering of Common Stock
MORRISVILLE, N.C., May 03, 2021 (GLOBE NEWSWIRE) — Syneos Health, Inc. (Nasdaq: SYNH) (the “Company”…
Santhera Announces Settlement of Exchange Offer and Issuance of New Senior Unsecured Convertible Bonds due 2024
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL…
Teligent, Inc. Announces 2020 Year-End Earnings Report and Provides Business Update
– Significantly strengthened balance sheet and cash position – Continued FDA Warning Letter remediation efforts…